Microangiopathic injury and augmented PAI-1 in human diabetic nephropathy
- 1 June 2002
- journal article
- Published by Elsevier BV in Kidney International
- Vol. 61 (6), 2142-2148
- https://doi.org/10.1046/j.1523-1755.2002.00384.x
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Peroxisome proliferator-activated receptor-γ agonist troglitazone protects against nondiabetic glomerulosclerosis in ratsKidney International, 2001
- Expression and Function of Peroxisome Proliferator–Activated Receptor-γ in Mesangial CellsHypertension, 2001
- Thiazolidinediones Down-Regulate Plasminogen Activator Inhibitor Type 1 Expression in Human Vascular Endothelial Cells: A Possible Role for PPARγ in Endothelial FunctionBiochemical and Biophysical Research Communications, 1999
- Mesangiolysis: An updateAmerican Journal of Kidney Diseases, 1998
- Modulation of plasminogen activator inhibitor-1 in vivo: A new mechanism for the anti-fibrotic effect of renin-angiotensin inhibitionKidney International, 1997
- Plasminogen Activator Inhibitor-1 Promoter 4G/5G Genotype and Plasma Levels in Relation to a History of Myocardial Infarction in Patients Characterized by Coronary AngiographyArteriosclerosis, Thrombosis, and Vascular Biology, 1997
- The Renin-Angiotensin and Fibrinolytic Systems: Co-Conspirators in the Pathogenesis of Ischemic Cardiovascular DiseaseTrends in Cardiovascular Medicine, 1996
- Analysis of the Plasminogen System on Rat Glomerular Epithelial CellsExperimental Cell Research, 1995
- Mesangiolytic Poststreptococcal GlomerulonephritisPediatric Pathology, 1992
- Secretory products of macrophages.JCI Insight, 1987